Skip to main content
. 2021 Nov 6;6(6):1376–1382. doi: 10.1002/lio2.695

TABLE 1.

Clinical and demographic patient factors

Non‐smoker Ever smoker P value
n = 76 n = 168
Age (mean [SD]) 55.51 (10.16) 57.11 (9.29) .229
Male (%) 65 (85.5) 143 (85.1) 1
Race (%) .47
Black 8 (10.5) 14 (8.3)
White 67 (88.2) 147 (87.5)
Other 1 (1.3) 2 (1.2)
Unknown 0 (0.0) 5 (3.0)
T‐stage (%) .78
Tis 0 (0.0) 1 (0.6)
T1‐2 51 (67.1) 114 (67.9)
T3‐4b 25 (32.9) 53 (31.5)
N‐stage (%) .16
0 9 (11.8) 20 (11.9)
1 13 (17.1) 13 (7.7)
2a‐c 48 (63.2) 116 (69.0)
3 6 (7.9) 19 (11.3)
M0 (%) 76 (100.0) 164 (97.6) .42
Treatment strategy (%) .63
Chemo‐radiation 52 (68.4) 102 (60.7)
Radiation therapy 3 (3.9) 12 (7.1)
Surgery alone 2 (2.6) 12 (7.1)
Surgery with adjuvant treatment 10 (13.2) 25 (14.9)
Induction chemo., chemo‐radiation 5 (6.6) 9 (5.4)
Induction chemo., surgery 4 (5.3) 8 (4.8)
Documented recurrence (%) 0.12 (0.33) 0.19 (0.39) .17
Pack‐years smoking (mean [SD]) 0 (0.0) 27.27 (22.24)
Clinical trial participation (%) .03
Yes 33 (43.4) 45 (26.8)
No 13 (17.1) 45 (26.8)
Unknown 30 (39.5) 78 (46.4)

Note: Patients were stratified by history of smoking exposure. Staging variables are reported according to AJCC7.